Upper Respiratory Tract Infection Treatment Market 2019-2023
A
key factor driving the growth of the market is the rising demand for
over-the-counter drugs. The market has witnessed a rising demand for
over-the-counter drugs for the treatment of upper respiratory tract
infections. Patients with common cold and cough often avoid consulting a
healthcare professional as the infection can be self-medicated with
over-the-counter drugs. Although, these drugs have increased the
practice of self-medication among individuals, thereby driving market
growth positively over the forecast period.
As
per Technavio, the emergence of biologics will have a positive impact
on the market and contribute to its growth significantly over the
forecast period. This global upper respiratory tract infection treatment market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.
Global upper respiratory tract infection treatment market: Emergence of biologics
Biologics
target specific immune cells within a disease process, further
increasing drug efficacy and reducing complications. The emergence of
biologics to treat upper respiratory tract infections will accelerate
market growth. For instance, researchers have found that a biologic
therapy known as omalizumab is the most promising therapy for chronic
rhinosinusitis. Omalizumab is a recombinant humanized monoclonal
antibody that binds to the free-circulating immunoglobulin E. According
to researchers, omalizumab may offer therapeutic improvements for both
allergic and nonallergic variants of chronic rhinosinusitis with nasal
polyposis. Thus, with such advances, the market for upper respiratory
tract infection treatment is expected to witness a positive outlook
during the forecast period.
Global upper respiratory tract infection treatment market: Segmentation analysis
This
market research report segments the global upper respiratory tract
infection treatment market by type (antibiotics, NSA IDs and nasal
decongestants, others) and geographical regions (North America, Europe,
Asia, and ROW).
The
North American region led the market in 2018, followed by Europe, Asia,
and ROW respectively. However, during the forecast period, the European
region is expected to register the highest incremental growth due to
the increase in the prevalence of upper respiratory tract infections.
Comments
Post a Comment